Jazz Pharmaceuticals (JAZZ) Interest Expenses (2010 - 2013)

Jazz Pharmaceuticals has reported Interest Expenses for 4 years, with the latest figure at $614000.0 in Q3 2013.

• For the quarter ending Q3 2013, Interest Expenses fell 44.13% year-over-year to $614000.0; the trailing twelve-month figure through Jun 2014 stood at $614000.0 (down 82.34% YoY), and the FY2013 full-year result was $1.7 million, down 53.12% from the prior year.
• Interest Expenses for Q3 2013 stood at $614000.0, up from $385000.0 in the prior quarter.
• The five-year high for Interest Expenses was $2.3 million in Q4 2012, with the low at -$570000.0 in Q4 2010.
• Average Interest Expenses over 4 years is $604363.6, with a median of $614000.0 recorded in 2013.
• Year-over-year, Interest Expenses soared 158.43% in 2011 and sank 63.58% in 2012.
• Tracing JAZZ's Interest Expenses over 4 years: stood at -$570000.0 in 2010, then jumped by 215.61% to $659000.0 in 2011, then soared by 243.4% to $2.3 million in 2012, then plunged by 72.87% to $614000.0 in 2013.
• The last three Interest Expenses figures came in at $614000.0 (Q3 2013), $385000.0 (Q2 2013), and -$271000.0 (Q1 2013), per Business Quant data.

Peer Comparison